HEMATOLOGY

Yves Laure Pimentel · 70問 · 2年前

通報

問題一覧

Which of the following poikilocyte is present? a. Codocytes b. Elliptocytes c. Blister cells d. Stomatocytes

d. Stomatocytes

Which of the following poikilocyte is being illustrated? a. Codocytes b. Elliptocytes c. Blister cells d. Stomatocytes

a. Codocytes

As the red blood cell matures, the overall cell diameter: a. Increases b. Decreases c. Remains the same d. None of the above

b. Decreases

IDENTIFY

ACANTHOCYTES ABETALIPOPROTEINEMIA MCLEOD PHENOMENON

IDENTIFY GIVEN DSE (2)

Echinocyte (Burr cell) UREMIA PK DEFICIENCY

IDENTIFY

Schistocytes MICROANGIPATHIC HEMOLYTIC ANEMIA -- HUS -- TTP -- DIC -- HELLP SYNDROME MACROANGIPATHIC HEMOLYTIC ANEMIA -- WARING BLENDER SYNDROME (HEART VALVES) -- MARCH HEMOGLOBINURIA

IDENTIFY

Spherocytes MCHC >36% IMMUNE HEMOLYTIC ANEMIA -- HDFN -- BURNS -- HEREDITARY SPHEROCYTOSIS

What is the immature erythrocyte found in the bone marrow with following characteristics: 12 to 17 mm in diameter, N:C ratio of 4:1, nucleoli not usually apparent, and basophilic cytoplasm? a. Rubriblast b. Reticulocyte c. Metarubricyte d. Prorubricyte

d. Prorubricyte

The alkaline denaturation test detects the presence of hemoglobin: a. A1c b. F c. C d. S

b. F

IDENTIFY

Ovalocyte LARGE OVALOCYTES -- MEGALOBLASTIC ANEMIA

Paroxysmal nocturnal hemoglobinuria exhibits sensitivity of one population of red blood cells to: a. Warm antibodies b. Cold antibodies c. Complement d. Either A or B

c. Complement

Contains DNA or nuclear fragments: a. Basophilic stippling b. Howell-Jolly body c. Heinz body d. Pappenheimer bodies

b. Howell-Jolly body

IDENTIFY

Elliptocyte HEREDITARY ELLIPTOCYTOSIS GERBICH NULL/ LEACH PHENOTYPE

IDENTIFY

Sickle cells DREPANOCYTES

IDENTIFY

Teardrop cells DACRYOCYTES -- MMM/ PRIMARY MYELOFIBROSIS (MYELOID METAPLASIA WITH MYELOFIBROSIS -- MYELOPTHISIC

What growth factors is produced by the kidneys and is used to treat anemia associated with kidney disease? a. EPO b. TPO c. KIT ligand d. G-CSF

a. EPO

IDENTIFY

Hb C crystals HEMOGLOBIN C DISEASE

IDENTIFY

Hb SC crystals

IDENTIFY

Howell-Jolly bodies

IDENTIFY

Basophilic stippling

The average diameter of a normal erythrocyte is ____ micrometer. a. 5.2 µm b. 6.4 µm c. 7.2 µm d. 8.4 µm

c. 7.2 µm

The greatest portion of operational body iron is normally contained in what compound? a. Hemoglobin b. ferritin c. Cytochromes d. Myoglobin

a. Hemoglobin

If globin synthesis is insufficient in a person, iron accumulates in the cell as _______ aggregates a. Transferrin b. Ferritin c. Albumin d. Heme

b. Ferritin

. Increased amounts of 2,3-BPG ____ the oxygen affinity of the hemoglobin molecule. a. Increases b. Decreases c. Does not alter d. None of the above

b. Decreases

Which of the following condition is characterized by the absence of CD55 (DAF) and CD59 (MIRL) on the surface of the RBCs rendering the it susceptible to spontaneous lysis by complement? a. PCH b. PNH c. HUS d. DIC

b. PNH

Physiologic programmed cell death: a. Angiogenesis b. Apoptosis c. Necrosis d. Apohematics

b. Apoptosis

The description of poikilocytosis is: a. Variation in erythrocyte size b. Larger than normal c. Smaller than normal d. Variation in erythrocyte shape

d. Variation in erythrocyte shape

f you are grading changes in erythrocytic size or shape using a scale of 0 to 4+ and many erythrocyte deviate from normal per microscopic field, the typical score would be: a. 1+ b. 2+ c. 3+ d. 4+

c. 3+

Acanthocytes (Spur cells) may be associated with the clinical condition of: a. Iron deficiency anemia b. Abetalipoproteinemia c. Pernicious anemia d. None of the above

b. Abetalipoproteinemia

Microspherocytes may be seen in: a. HD (Hepatic disease) b. HDFN (Hemolytic disease of the fetus and newborn) c. PA (Pernicious anemia) d. HB (Hemoglobinopathies)

b. HDFN (Hemolytic disease of the fetus and newborn)

What is the appropriate reagent for reticulocyte counting? a. New methylene blue b. Phloxine B c. Solution that can lyse erythrocyte and darken the cell to be counted d. None of the above

a. New methylene blue

In the preparation of films for reticulocyte counting, what is the ratio of blood to the stain? a. 1:2 b. 2:1 c. 3:1 d. 1:1

d. 1:1

Disease characterized with a poikilocyte with membrane folded over (Fold cells): a. Sickle cell anemia b. Hemoglobin C disease c. Hemoglobin H disease d. Bart’s hemoglobin

b. Hemoglobin C disease

Schistocytes: a. Fragmented RBC b. RBC with no central pallor c. Crenated RBC d. Swollen RBC

a. Fragmented RBC

Bite cells: a. PK deficiency b. G6PD deficiency c. PK and G6PD deficiency d. None of the above

b. G6PD deficiency

A screening test for PNH is: a. Heat instability test b. Sucrose hemolysis test c. Osmotic fragility d. Dithionite solubility

b. Sucrose hemolysis test

Patient with thrombocytopenia, decrease in hemoglobin, fragmented RBCs. Which of the following diseases is the most probable cause? a. HUS b. ITP c. HHT d. None of the above

a. HUS

What is the formula for RDW? a. SD x 100/mean b. HCT/RBC x 10 c. HGB/RBC x 10 d. HGB/HCT x 100

a. SD x 100/mean

Which of the following metabolic pathway prevents oxidation of heme iron? a. Embden-Meyerhof pathway b. Hexose-monophosphate pathway c. Methemoglobin reductase pathway d. Luebering-Rapaport pathway

c. Methemoglobin reductase pathway

If the RBC distribution on a histogram demonstrates a homogenous pattern and a small SD, the peripheral blood smear would probably exhibit: a. Extreme anisocytosis b. Very little anisocytosis c. A single population of spherocytes d. A single population of macrocytes

b. Very little anisocytosis

The RDW and MCV are both quantitative descriptors of RBC size. If both are increased, the most probable erythrocytic abnormality would be: a. Iron deficiency anemia b. Acquired aplastic anemia c. Megaloblastic anemia d. Hemoglobinopathy

c. Megaloblastic anemia

What is the most common mechanism resulting in hereditary stomatocytosis? a. A deficient cytoskeletal protein b. Inability to repair oxidative stress damage c. Abnormal Na+/K+ permeability d. ATP depletion due to glycolytic enzyme deficiency

c. Abnormal Na+/K+ permeability

The stages of neutrophilic granulocyte development are a. promyelocyte, myeloblast, myelocyte, metamyelocyte, and band and segmented neutrophils b. myeloblast, promyelocyte, myelocyte, metamyelocyte, and band and segmented neutrophils c. myelocyte, myeloblast, promyelocyte, metamyelocyte, and band and segmented neutrophils d. myeloblast, promyelocyte, metamyelocyte, myelocyte, and band and segmented neutrophils

b. myeloblast, promyelocyte, myelocyte, metamyelocyte, and band and segmented neutrophils

Azurophilic granules were produced in what stage? a. Promyelocyte b. Myelocyte c. Metamyelocyte d. Band

a. Promyelocyte

Cells that produces antibodies and lymphokines: a. Erythrocytes b. Granulocytes c. Lymphocytes d. Thrombocytes

c. Lymphocytes

Which one of the following cells is a product of the CLP? a. Megakaryocytes b. T lymphocyte c. Erythrocyte d. Granulocyte

b. T lymphocyte

In Gaucher disease, as the result of βglucocerebrosidase deficiency, what accumulates in (macrophages) histiocytes? a. Glucocerebroside and sphingomyelin b. Glucocerebroside c. Sphingomyelin d. None of the above

b. Glucocerebroside

Niemann-Pick disease affects which cell type? a. Neutrophils b. Lymphocytes c. Erythrocytes d. Platelets

b. Lymphocytes

Which antibody test has replaced the LE cell preparation in the diagnosis of SLE? a. Rheumatoid arthritis factor b. ANA test c. Complement fixation test d. Antibody Smith test

b. ANA test

The abnormal protein frequently found in the urine of persons with multiple myeloma is: a. Albumin b. Globulin c. IgG d. Bence Jones

d. Bence Jones

The WHO classification requires what percentage for the blast count in the blood or bone marrow for the diagnosis of AML? a. At least 30% b. At least 20% c. At least 10% d. Any percentage

b. At least 20%

Which of the following refers to the number, form, size, and arrangement of chromosomes within the nucleus? a. Punnett squares b. Karyotyping c. Phage typing d. None of the above

b. Karyotyping

Occur when there is a breakage in two chromosomes and each of the broken pieces reunites with another chromosomes: a. Inversion b. Translocation c. Mutation d. None of the above

b. Translocation

What influence does the Philadelphia (Ph1) chromosome have on the prognosis of patients with CML? a. It is not predictive b The prognosis is better if Ph1 is present c. The prognosis is worse if Ph1 is present d. The disease usually transforms into AML when Ph1 is present

b The prognosis is better if Ph1 is present

An acute leukemia can be described as being: a. of short duration with many mature leukocyte forms in the peripheral blood b. of short duration with many immature leukocyte forms in the peripheral blood c. of short duration with little alteration of the leukocytes of the peripheral blood d. of long duration with many mature leukocyte forms in the peripheral blood

b. of short duration with many immature leukocyte forms in the peripheral blood

Hematopoietic stem cells produce all lineages of blood cells in sufficient quantities over the lifetime of an individual because they: a. Are unipotent b. Have the ability of self-renewal by asymmetric division c. Are present in large numbers in the bine marrow niches d. Have a low mitotic potential in response to growth factors.

b. Have the ability of self-renewal by asymmetric division

Promyelocytes predominate in the bone marrow: a. M1 b. M2 c. M3 d. M4

c. M3

Which of the cytokine has the current/potential therapeutic application as an adjuvant for infectious disease therapy? a. IL-3 b. GM-CSF c. IL-12 d. IFN-a

c. IL-12

Three-part differential: a. Lymphocytes, monocytes, and granulocytes b. Lymphocytes, mononuclear, and granulocytes c. Lymphocytes, monocytes, neutrophil d. Lymphocyte, monocyte, neutrophil, eosinophil

b. Lymphocytes, mononuclear, and granulocytes

Electrical impedance principle of cell counting was originally developed by: a. Coulter b. Abbott c. Beckman d. Sysmex

a. Coulter

In the photo-optical method, the change in light transmission versus the _____ is used to determine the activity of coagulation factors or stages. a. amount of patient’s plasma b. amount of test reagent c. time d. temperature

c. time

When a specimen has been flagged as being icteric by an automated coagulation analyzer, which method would be most susceptible to erroneous results because of interfering substance? a. Mechanical clot detection b. Immunologic antigen-antibody reaction detection c. Photo-optical clot detection d. Chromogenic end-point detection

c. Photo-optical clot detection

The abbreviation laser stands for a. light-associated simulated emission of radiation b. largely amplified by simulated emission of radiation c. light amplified by stimulated emission of radiation d. liquid amplified by stimulated emission of radiation

c. light amplified by stimulated emission of radiation

Which parameters are calculated rather than directly measured? a. Hematocrit and erythrocyte distribution width b. Erythrocyte count and leukocyte count c. Leukocyte count and hematocrit d. Platelet count and platelet volume

a. Hematocrit and erythrocyte distribution width

In an erythrocyte histogram, the erythrocytes that are larger than normal will be to the _____ of the normal distribution curve. a. Right b. Left c. In the middle d. Bimodal

a. Right

The major application of flow-cytometry is: a. Determining cell size and granularity b. Sorting of cells and cellular identification using monoclonal antibodies c. Treating cancer cells and identifying specific virus types d. Counting leukocytes and platelets

b. Sorting of cells and cellular identification using monoclonal antibodies

A combined scatter histogram measure: a. Overall size versus nuclear size b. Cell size and granularity c. Cell shape and cytoplasmic color d. Cytoplasm to nucleus ratio

b. Cell size and granularity

What is the principle of mechanical endpoint detection in coagulation instruments: a. Decrease in light transmittance as fibrin forms b. Increase in light absorbance as latex particles coated with sepcific antibody are agglutinated by antigen c. Increase in light absorbance at 405 nm as paranitroaniline is cleaved from synthetic substrate by the coagulation enzyme d. Change in movement of steel ball when clot forms

d. Change in movement of steel ball when clot forms

Anticoagulant to avoid platelet satellitism: a. EDTA b. Oxalate c. Citrate d. Heparin

c. Citrate

Which characteristic is inaccurate with respect to the anticoagulant K3 EDTA? a. Removes ionized calcium from fresh whole blood by the process of chelation b. Is the most commonly used anticoagulant in hematology c. Is conventionally placed in lavender-stoppered tubes. d. Is used for most routine coagulation studies

d. Is used for most routine coagulation studies

If a blood smear stains too red on microscopic examination of Wright-stained preparation, possible causes include that: a. The staining time was too long b. The stain was too basic c. The buffer was too acidic and the exposure time was too short d. The buffer was too basic and the exposure time was too long

c. The buffer was too acidic and the exposure time was too short

Acceptable limits of control value must fall: a. Within ±1SD of the mean b. Within 1 and 2 SD of the mean c. Within ±2 SD of the mean d. Within ±3 SD of the mean

c. Within ±2 SD of the mean

The delta check method of quality control a. uses the patient’s own data to monitor population values b. uses batches of 20 samples to track MCV, MCH, and MCHC values c. compares the patient’s leukocyte and platelet counts with his or her previous results d. monitors the patient’s values within two SDs of the mean

c. compares the patient’s leukocyte and platelet counts with his or her previous results

The reagent used in the traditional sickle screening test is: a. Sodium chloride b. Sodium metabisulfite d. Sodium citrate d. None of the above

b. Sodium metabisulfite

What clinical condition will produce a decreased Westergren ESR value? a. Polycythemia vera b. Acute leukemia c. Viral infection d. Megaloblastic anemia

a. Polycythemia vera

What is the appropriate procedure and characteristic for the Westergren method? a. The diluting solution lyses erythrocytes with propylene glycol and contains sodium carbonate and water. b. The procedure measures the rate of erythrocyte settling. c. Ferrous ions are oxidized to the ferric state. d. The diluting solution is either 1% HCl or 2% acetic acid.

b. The procedure measures the rate of erythrocyte settling.

Which test is most affected when there is excessive anticoagulant? a. RBC count b. ESR c. Hemoglobin d. Hematocrit

d. Hematocrit

The normal range for reticulocytes in adults is: a. 0 to 0.5% b. 0.5% to 1.0% c. 0.5% to 1.5% d. 1.5% to 2.5%

c. 0.5% to 1.5%

Using white blood cell as the reference, what is the effect of leukemia in the ESR? a. Increased b. Decreased c. Variable d. None of the above

a. Increased

Using white blood cell as the reference, what is the effect of leukocytosis in the ESR? a. Increased b. Decreased c. Variable d. None of the above

b. Decreased

Megakaryopoiesis is associated with: a. Endomitosis b. Meiosis c. Mitosis d. None of the above

a. Endomitosis

The cellular ultrastructural component unique to platelet is: a. Cytoplasmic membrane b. Mitochondria c. Microtubules d. Glycocalyx

d. Glycocalyx

Platelet aggregation will occur with the end product of: a. Cyclooxygenase b. Arachidonic acid c. Prostacyclin d. Thromboxane A2

d. Thromboxane A2

Which of the following blood film findings indicates EDTA-induced pseudo thrombocytopenia? a. The platelets are pushed to the feathered end b. The platelets are adhering to WBCs c. No platelets at all are seen on the film d. The slide has a bluish discoloration when examined macroscopically

b. The platelets are adhering to WBCs

Agents that are capable of aggregating platelets include: a. Collagen b. Thrombin c. Serotonin d. All of the above

d. All of the above

Which organ is the site of sequestration of platelets? a. Liver b. Thymus c. Spleen d. Bone marrow

c. Spleen

An example of an acquired platelet dysfunction: a. Uremia b. von Willebrand’s disease c. Aspirin ingestion d. None of the above

a. Uremia

The clot retraction test is: a. A visible reaction to the activation of platelet actomyosin (thrombasthenin) b. A reflection of the quantity and quality of platelets and other factors c. A measurement of the ability of platelets to stick to glass d. A measurement of the cloudiness of blood

b. A reflection of the quantity and quality of platelets and other factors

The bleeding time test measures a. the ability of platelets to stick together b. platelet adhesion and aggregation on locally injured vascular subendothelium c. the quantity and quality of platelets d. antibodies against platelets

b. platelet adhesion and aggregation on locally injured vascular subendothelium

Fletcher factor: a. Prekallikrein b. HMWK c. Factor XI d. Factor XII

a. Prekallikrein

Which clotting factors (cofactors) are inhibited by protein S? a. Factor V and X b. Factor Va and VIIIa c. Factor VIII and IX d. Factor VIII and X

b. Factor Va and VIIIa

Refer to the following results: PT= prolonged APTT= prolonged PLT count= decreased Which disorder may be indicated? a. Factor VIII deficiency b. von Willebrand disease c. Disseminated intravascular coagulation d. Factor IX deficiency

c. Disseminated intravascular coagulation

The function of thromboplastin in the prothrombin test is to provide _____ to the assay. a. Kaolin b. Fibrinogen c. Phospholipoprotein d. Thrombin

c. Phospholipoprotein

The intrinsic pathway of coagulation BEGINS with the activation of _____ in the early stage. a. Factor II b. Factor I c. Factor XII d. Factor V

c. Factor XII

Abnormal results in dysfibrinogenemia, except: a. PT b. aPTT c. TT d. Fibrinogen level

d. Fibrinogen level

Single factor deficiency with normal PT, PTT, and TCT: a. I b. XI c. XIII d. II

c. XIII

PT is performed in what temperature? a. 4 degrees Celsius b. 20 degrees Celsius c. 37 degrees Celsius d. 38 degrees Celsius

c. 37 degrees Celsius

If a child ingested rat poison, which of the following tests should be performed to test the effect of the poison on the child’s coagulation mechanism? a. aPTT b. PT c. Fibrinogen assay d. None of the above

b. PT

The deficient factor is factor VIII. What would be the result for PT, PTT, and TCT, respectively, using clot-based screening assays? a. Normal, prolonged, normal b. Prolonged, prolonged, prolonged c. Prolonged, normal, normal d. Prolonged, normal, prolonged

a. Normal, prolonged, normal

100

. Fibrinogen level in patients with hemophilia A, B and C? a. Decreased, normal, decreased b. Normal, normal, normal c. Decreased, decreased, decreased d. Normal, decreased, decreased

b. Normal, normal, normal

other names parasitology

other names parasitology

70問 • 2年前

Yves Laure Pimentel · 111問 · 2年前

PARASITOLOGY

PARASITOLOGY

111問 • 2年前

Yves Laure Pimentel · 64問 · 2年前

HTMLBE

HTMLBE

64問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

61問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

HISTOPATHOLOGY

HISTOPATHOLOGY

69問 • 2年前

CC-2 SPECTROPHOTOMETRY

CC-2 SPECTROPHOTOMETRY

Yves Laure Pimentel · 41問 · 2年前

CC-3 ELECTROPHORESIS

CC-3 ELECTROPHORESIS

41問 • 2年前

Yves Laure Pimentel · 87問 · 2年前

AUBF LAB SAFETY

AUBF LAB SAFETY

87問 • 2年前

CSF 1

CSF 1

Yves Laure Pimentel · 82問 · 2年前

CSF 2

CSF 2

82問 • 2年前

SEMEN 1

SEMEN 1

Yves Laure Pimentel · 7問 · 2年前

SEMEN 2

SEMEN 2

7問 • 2年前

SYNOVIAL FLUID 1

SYNOVIAL FLUID 1

Yves Laure Pimentel · 6問 · 2年前

SYNOVIAL FLUID 2

SYNOVIAL FLUID 2

6問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

SEROUS FLUID

SEROUS FLUID

25問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

PLEURAL FLUID

PLEURAL FLUID

44問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

PERICARDIAL FLUID

PERICARDIAL FLUID

18問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

PERITONEAL FLUID/ ASCITIC FLUID

PERITONEAL FLUID/ ASCITIC FLUID

30問 • 2年前

Yves Laure Pimentel · 92問 · 2年前

AMNIOTIC FLUID

AMNIOTIC FLUID

92問 • 2年前

Yves Laure Pimentel · 80問 · 2年前

FECALYSIS

FECALYSIS

80問 • 2年前

Yves Laure Pimentel · 89問 · 2年前

OTHER BODY FLUIDS

OTHER BODY FLUIDS

89問 • 2年前

Yves Laure Pimentel · 86問 · 2年前

MTLBE- SUHO NOTES

MTLBE- SUHO NOTES

86問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

MTLBE..

MTLBE..

35問 • 2年前

Yves Laure Pimentel · 19問 · 1年前

CC- CHROMATOGRAPHY

CC- CHROMATOGRAPHY

19問 • 1年前

Yves Laure Pimentel · 14問 · 1年前

CC-OSMOMETRY

CC-OSMOMETRY

14問 • 1年前

Yves Laure Pimentel · 43問 · 1年前

CC-ELECTROCHEMISTRY TECHNIQUES

CC-ELECTROCHEMISTRY TECHNIQUES

43問 • 1年前

Yves Laure Pimentel · 49問 · 2年前

CC- CARBOHYDRATES

CC- CARBOHYDRATES

49問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

CC- DIABETES MELLITUS

CC- DIABETES MELLITUS

97問 • 2年前

Yves Laure Pimentel · 57問 · 2年前

MAJOR LIPOPROTEINS

MAJOR LIPOPROTEINS

57問 • 2年前

Yves Laure Pimentel · 63問 · 2年前

MINOR LIPOPROTEINS

MINOR LIPOPROTEINS

63問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PROTEINS

PROTEINS

37問 • 2年前

Yves Laure Pimentel · 91問 · 2年前

PLASMA PROTEINS 1

PLASMA PROTEINS 1

91問 • 2年前

Yves Laure Pimentel · 98問 · 2年前

PLASMA PROTEINS 2 (ALPHA 2 REGION)

PLASMA PROTEINS 2 (ALPHA 2 REGION)

98問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

MISCELLANEOUS PROTEINS

MISCELLANEOUS PROTEINS

61問 • 2年前

Liver Function Test 1

Liver Function Test 1

Yves Laure Pimentel · 96問 · 2年前

Liver Function Test 2

Liver Function Test 2

96問 • 2年前

Yves Laure Pimentel · 33問 · 2年前

TUMOR MARKERS

TUMOR MARKERS

33問 • 2年前

Yves Laure Pimentel · 41問 · 2年前

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

41問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

GLYCOGEN STORAGE DISEASES

GLYCOGEN STORAGE DISEASES

17問 • 2年前

Yves Laure Pimentel · 14問 · 2年前

LIPID STORAGE DISEASES

LIPID STORAGE DISEASES

14問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

PROTEINS

PROTEINS

71問 • 2年前

Yves Laure Pimentel · 7問 · 2年前

QUICK FIRE- ELECTRODES

QUICK FIRE- ELECTRODES

7問 • 2年前

Yves Laure Pimentel · 10問 · 2年前

ELECTROLYTES

ELECTROLYTES

10問 • 2年前

Yves Laure Pimentel · 27問 · 2年前

DRUGS

DRUGS

27問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

TOXIC AGENTS:

TOXIC AGENTS:

12問 • 2年前

HEMATOLOGY 1 (HEMATOPOIESIS 1)

HEMATOLOGY 1 (HEMATOPOIESIS 1)

Yves Laure Pimentel · 29問 · 2年前

HEMATOLOGY (HEMATOPOIESIS 2)

HEMATOLOGY (HEMATOPOIESIS 2)

29問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

hema diseases

hema diseases

25問 • 2年前

Yves Laure Pimentel · 43問 · 2年前

AML

AML

43問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

GLOBIN SYNTHESIS

GLOBIN SYNTHESIS

71問 • 2年前

Yves Laure Pimentel · 31問 · 2年前

HEMATOLOGY REFERENCE RANGES

HEMATOLOGY REFERENCE RANGES

31問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

DISORDERS OF PRIMARY HEMOSTASIS

DISORDERS OF PRIMARY HEMOSTASIS

34問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PLATELET DISORDERS

PLATELET DISORDERS

37問 • 2年前

CHARACTERISTICS OF CLOTTING FACTORS

CHARACTERISTICS OF CLOTTING FACTORS

Yves Laure Pimentel · 12問 · 2年前

4. CLASSIFICATION OF MACROPHAGE

4. CLASSIFICATION OF MACROPHAGE

12問 • 2年前

Yves Laure Pimentel · 39問 · 2年前

3. NATURAL OR INNATE IMMUNITY

3. NATURAL OR INNATE IMMUNITY

39問 • 2年前

Yves Laure Pimentel · 55問 · 2年前

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

55問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

6. PHAGOCYTOSIS Chemotaxis

6. PHAGOCYTOSIS Chemotaxis

37問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

8. NATURE OF ANTIGEN

8. NATURE OF ANTIGEN

44問 • 2年前

Yves Laure Pimentel · 50問 · 2年前

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

50問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

1. HISTORY

1. HISTORY

69問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. TYPES OF IMMUNITY

2. TYPES OF IMMUNITY

38問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

7. PHAGOCYTOSIS Engulfment and Digestion

7. PHAGOCYTOSIS Engulfment and Digestion

21問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

8. PHAGOCYTOSIS EXOCYTOSIS

8. PHAGOCYTOSIS EXOCYTOSIS

15問 • 2年前

Yves Laure Pimentel · 32問 · 2年前

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

32問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

11. TRANSPLANTATION IMMUNOLOGY

11. TRANSPLANTATION IMMUNOLOGY

30問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. LYMPHOID ORGANS

2. LYMPHOID ORGANS

38問 • 2年前

Yves Laure Pimentel · 48問 · 2年前

3. CLUSTER OF DIFFERENTIATION

3. CLUSTER OF DIFFERENTIATION

48問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

4. T-CELL DIFFERENTIATION

4. T-CELL DIFFERENTIATION

35問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

5. T CELL IMMUNODEFICIENCIES

5. T CELL IMMUNODEFICIENCIES

18問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

44問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

7. B CELL IMMUNODEFICIENCIES

7. B CELL IMMUNODEFICIENCIES

23問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

8. COMBINED T CELL AND B CELL DEFICIENCIES

8. COMBINED T CELL AND B CELL DEFICIENCIES

34問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

9. COMPARISON OF T AND B CELLS

9. COMPARISON OF T AND B CELLS

12問 • 2年前

Yves Laure Pimentel · 16問 · 2年前

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

16問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

15問 • 2年前

Yves Laure Pimentel · 79問 · 2年前

12. ANTIBODY

12. ANTIBODY

79問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

13. TYPES OF ANTIBODIES

13. TYPES OF ANTIBODIES

97問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

14. MONOCLONAL ANTIBODIES

14. MONOCLONAL ANTIBODIES

11問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

1. INTERLEUKINS

1. INTERLEUKINS

23問 • 2年前

Yves Laure Pimentel · 28問 · 2年前

2. INTERFERONS

2. INTERFERONS

28問 • 2年前

Yves Laure Pimentel · 8問 · 2年前

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

8問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

4. COMPLEMENT SYSTEM

4. COMPLEMENT SYSTEM

19問 • 2年前

Yves Laure Pimentel · 76問 · 2年前

15. COMPLEMENT SYSTEM

15. COMPLEMENT SYSTEM

76問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

21問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

17. COMPLEMENT AND DISEASE STATES

17. COMPLEMENT AND DISEASE STATES

29問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

19問 • 2年前

Yves Laure Pimentel · 22問 · 2年前

19. CYTOKINES

19. CYTOKINES

22問 • 2年前

Yves Laure Pimentel · 24問 · 2年前

20. INTERLEUKINS

20. INTERLEUKINS

24問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

21. INTERFERONS, TNF, TGF, CHEMOKINE

21. INTERFERONS, TNF, TGF, CHEMOKINE

21問 • 2年前

Yves Laure Pimentel · 54問 · 2年前

1. SERO

1. SERO

54問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. PRECIPITATION

2. PRECIPITATION

38問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

3. PASSIVE IMMUNODIFFUSION

3. PASSIVE IMMUNODIFFUSION

17問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

4. OUCHTERLONY

4. OUCHTERLONY

15問 • 2年前

Yves Laure Pimentel · 9問 · 2年前

5. ELECTROPHORETIC TECHNIQUE

5. ELECTROPHORETIC TECHNIQUE

9問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

11問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

7. IMMUNOFIXATION ELECTROPHORESIS

7. IMMUNOFIXATION ELECTROPHORESIS

29問 • 2年前